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Abstract. 
 
Sphingosine-1-phosphate (SPP), a bioactive 
lipid, acts both intracellularly and extracellularly to 
cause pleiotropic biological responses. Recently, we 
identified SPP as a ligand for the G protein–coupled re-
ceptor Edg-1 (Lee, M.-J., J.R. Van Brocklyn, S. 
Thangada, C.H. Liu, A.R. Hand, R. Menzeleev, S. 
Spiegel, and T. Hla. 1998. 
 
Science
 
. 279:1552–1555). 
Edg-1 binds SPP with remarkable specificity as only 
sphinganine-1-phosphate displaced radiolabeled SPP, 
while other sphingolipids did not. Binding of SPP to 
Edg-1 resulted in inhibition of forskolin-stimulated 
cAMP accumulation, in a pertussis toxin–sensitive 
manner. In contrast, two well-characterized biological 
responses of SPP, mitogenesis and prevention of apop-
tosis, were clearly unrelated to binding to Edg-1 and 
correlated with intracellular uptake. SPP also stimu-
lated signal transduction pathways, including calcium 
mobilization, activation of phospholipase D, and ty-
rosine phosphorylation of p125
 
FAK
 
, independently of 
 
edg-1
 
 expression. Moreover, DNA synthesis in Swiss 
3T3 fibroblasts was significantly and specifically in-
creased by microinjection of SPP. Finally, SPP sup-
presses apoptosis of HL-60 and pheochromocytoma 
PC12 cells, which do not have specific SPP binding or 
expression of Edg-1 mRNA. Conversely, sphinganine-
1-phosphate, which binds to and signals via Edg-1, does 
not have any significant cytoprotective effect. Thus, 
SPP is a prototype for a novel class of lipid mediators 
that act both extracellularly as ligands for cell surface 
receptors and intracellularly as second messengers.
Key words: sphingolipids • mitogenesis • G proteins • 
apoptosis • signal transduction
 
S
 
phingolipid
 
 metabolites, ceramide, sphingosine, and
sphingosine-1-phosphate (SPP),
 
1
 
 are emerging as
members of a new class of lipid second messengers
(Kolesnick and Fuks, 1995; Spiegel and Milstien, 1995;
Hannun, 1996). Ceramide, formed by receptor-coupled ac-
tivation of sphingomyelinase, has been associated with cell
growth arrest and is an important component of stress re-
sponses and apoptosis (Hannun, 1996), whereas SPP, a
further metabolite of ceramide, is mitogenic in diverse cell
types (Zhang et al., 1991; Bornfeldt et al., 1995; Gomez-
Munoz et al., 1995; Pyne et al., 1996) and opposes cer-
amide-mediated apoptosis (Cuvillier et al., 1996; Edsall et
al., 1997). Thus, we have proposed that the relative intra-
cellular levels of these two sphingolipid metabolites is an
important factor that determines whether cells will survive
or die (Cuvillier et al., 1996). More recently, it has been
demonstrated that this ceramide/SPP rheostat is an evolu-
tionarily conserved stress regulatory mechanism influenc-
ing growth and survival of yeast (Mandala et al., 1997).
Various stimuli, including PDGF and serum (Olivera
and Spiegel, 1993; Bornfeldt et al., 1995), NGF (Edsall et al.,
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1. 
 
Abbreviations used in this paper
 
: BrdU, bromodeoxyuridine; C2-cer-
amide, 
 
N
 
-acetyl sphingosine; C8-cer-1-P, 
 
N
 
-octanoyl ceramide-1-phos-
phate; fura-2/AM, fura-2/acetoxy-methyl ester; IBMX, 3-isobutyl-1-meth-
ylxanthine; LPA, lysophosphatidic acid; MAP, mitogen-activating protein;
RIgG, rabbit IgG; p125
 
FAK
 
, p125 focal adhesion kinase; SPC, sphingo-
sylphosphorylcholine; SPP, sphingosine-1-phosphate.
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1997), activation of protein kinase C (Mazurek et al., 1994;
Buehrer et al., 1996), and cross-linking of the Fc
 
e
 
RI recep-
tor by antigens (Choi et al., 1996), increase cellular levels
of SPP by activation of sphingosine kinase, the enzyme
that catalyzes the phosphorylation of sphingosine. Com-
petitive inhibitors of sphingosine kinase eliminate forma-
tion of SPP and selectively block cellular proliferation in-
duced by PDGF and serum (Olivera and Spiegel, 1993;
Rani et al., 1997), as well as Fc
 
e
 
RI-mediated calcium sig-
naling (Choi et al., 1996) and the cytoprotective effects of
cytokines (Cuvillier et al., 1996) and NGF (Edsall et al.,
1997), further supporting a role for endogenous SPP.
Although many studies indicate an intracellular site of
action of SPP, some of its biological effects when added
exogenously may be due to binding to cell surface recep-
tors. SPP is stored in high concentrations and is released
from human platelets upon activation by physiological
stimuli (Yatomi et al., 1995), and it is present at high levels
in serum (Yatomi et al., 1997
 
b
 
). Previously, we have shown
that pertussis toxin–sensitive G proteins are involved in
some of the signaling pathways activated by SPP, suggesting
that it might activate a receptor coupled to a G
 
i
 
/G
 
o
 
-protein
(Goodemote et al., 1995). In agreement, low concentrations
of SPP activate G
 
i
 
 protein–gated inward rectifying K
 
1
 
-
channels only when applied at the extracellular face of
atrial myocytes (van Koppen et al., 1996). Moreover, na-
nomolar concentrations of SPP (EC
 
50
 
 5 
 
2 nM) rapidly in-
duced Rho-dependent neurite retraction and cell rounding
of mouse N1E-115 neurons (Postma et al., 1996) and
markedly inhibited melanoma cell motility by binding to
an extracellular receptor (Yamamura et al., 1997).
Recently, we identified Edg-1 as the receptor for SPP
and demonstrated that binding of SPP to Edg-1 induces
morphogenetic differentiation via a Rho-dependent sig-
naling pathway (Lee et al., 1998). 
 
edg-1
 
 was cloned as an
immediate-early gene induced by phorbol ester treatment
of human umbilical vein endothelial cells (Hla and Ma-
ciag, 1990) and is thought to be involved in endothelial cell
differentiation (Hla and Maciag, 1990; Lee et al., 1998).
Here we report that SPP has dual actions. In addition to
signaling through a cell surface G
 
i
 
-coupled receptor, SPP
acts intracellularly to regulate cellular proliferation and
suppression of apoptosis.
 
Materials and Methods
 
Materials
 
SPP, dihydrosphingosine-1-phosphate (dihydro-SPP), sphingosine, 
 
N
 
,
 
N
 
-
dimethylsphingosine, and 
 
N
 
-acetyl sphingosine (C2-ceramide) were pur-
chased from BIOMOL Research Laboratory, Inc. (Plymouth Meeting,
PA). 
 
N
 
-octanoyl ceramide-1-phosphate (C8-ceramide-1-P) was from Cal-
biochem (La Jolla, CA). Other lipids were purchased from Avanti Polar
Lipids (Birmingham, AL). SPP-phosphonate was kindly provided by Dr.
Richard R. Schmidt (University of Konstanz, Konstanz, Germany).
[methyl-
 
3
 
H]Thymidine (83 Ci/mmol) and [
 
g
 
-
 
32
 
P]ATP (3,000 Ci/mmol)
were purchased from Amersham Corp. (Arlington Heights, IL). Fura-2/
acetoxy-methyl ester (fura-2/AM) was from Molecular Probes, Inc. (Eu-
gene, OR). Serum and medium were obtained from Biofluids, Inc. (Rock-
ville, MD). Pertussis toxin was from List Biological Labs (Campbell, CA).
 
Cell Culture
 
Human embryonic kidney cells (HEK293, ATCC CRL-1573 [American
Type Culture Collection, Rockville, MD]) stably transfected with epitope-
tagged human 
 
edg-1
 
 cDNA in the pcDNANeo expression vector or pcD-
NANeo control vector and NIH 3T3 fibroblasts (ATCC CRL-1658) stably
transfected with pMexNeo vector or pMexNeo containing FLAG-tagged
 
edg-1
 
 were grown in DME containing 10% fetal bovine serum, 0.25 g/liter
G418 sulfate (Biofluids, Inc.) as previously described (Lee et al., 1996,
1998). Swiss 3T3 cells (ATCC CCL-92) were subcultured at a density of
1.5 
 
3 
 
10
 
4
 
 cells/cm
 
2
 
 in DME supplemented with 2 mM glutamine and 10%
calf serum, refed with the same medium after 2 d, and used 5 d later when
the cells were confluent and quiescent (Olivera and Spiegel, 1993). Rat
pheochromocytoma PC12 cells (ATCC CRL-1721) were maintained in
RPMI medium supplemented with 10% heat-inactivated horse serum, 5%
fetal bovine serum, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin (Ed-
sall et al., 1997). Human promyelocytic HL-60 cells (ATCC CCL-240)
were grown in RPMI 1640 containing 10% fetal bovine serum as previ-
ously described (Cuvillier et al., 1996).
 
Sphingosine-1-Phosphate Binding Assay
 
[
 
32
 
P]SPP was synthesized enzymatically using partially purified sphin-
gosine kinase as previously described (Olivera et al., 1994). The specific
activity of [
 
32
 
P]SPP was 1.28 
 
3 
 
10
 
6
 
 cpm/pmol. Cells were incubated with
1 nM [
 
32
 
P]SPP (200,000 cpm) in 200 
 
m
 
l binding buffer (20 mM Tris-HCl,
pH 7.4, 100 mM NaCl, 15 mM NaF, 2 mM deoxypyridoxine, 0.2 mM
PMSF, 1 
 
m
 
g/ml aprotinin and leupeptin) for 30 min at 4
 
8
 
C. Unlabeled lipid
competitors were added as 4 mg/ml fatty acid-free BSA complexes
(Zhang et al., 1991). Cells were washed twice with 200 
 
m
 
l ice-cold binding
buffer containing 0.4 mg/ml fatty acid-free BSA and resuspended in PBS,
and bound [
 
32
 
P]SPP was quantitated by scintillation counting.
 
Measurement of Cyclic AMP Levels
 
Cells were incubated for 15 min at 37
 
8
 
C in DME containing the phospho-
diesterase inhibitor IBMX (0.5 mM), in the absence or presence of 10 
 
m
 
M
forskolin, and the indicated concentration of SPP or vehicle. Medium was
then aspirated, cells were washed with PBS, and cAMP was extracted by
sonication in 4 mM EDTA. After centrifugation, samples were boiled for
3 min and recentrifuged, and cAMP was measured using the Biotrak
[
 
3
 
H]cAMP assay system (Amersham Corp.) according to the manufac-
turer’s instructions.
 
Measurement of DNA Synthesis
 
Cells were grown to confluence in 24-well tissue culture plates, washed
with serum-free DME containing 5 
 
m
 
g/ml transferrin and 20 
 
m
 
g/ml BSA,
stimulated by the addition of the indicated concentration of SPP, and after
16 h, pulsed with 1.0 
 
m
 
Ci of [
 
3
 
H]thymidine for 8 h. Incorporation of
[
 
3
 
H]thymidine into trichloroacetic acid–insoluble material was measured
as described (Olivera et al., 1992). Values are the means of triplicate de-
terminations, and standard deviations were routinely less than 10% of the
mean.
 
Northern Hybridization
 
Total RNA from various cell lines was extracted by the acid guanidine
thiocyanate/phenol/chloroform method (Chomczynski and Sacchi, 1987).
RNA (10 
 
m
 
g) was electrophoresed on 1% agarose/formaldehyde gels and
transferred to Zeta-probe membranes (Bio-Rad Laboratories, Hercules,
CA). Mouse 
 
edg-1
 
 cDNA probe was labeled with [
 
a
 
-
 
32
 
P]dCTP using a
random primer labeling kit (Amersham Corp.). Membranes were hybrid-
ized as described previously (Liu and Hla, 1997) and exposed to x-ray film
for autoradiography.
 
Measurement of Uptake and Metabolism of SPP
 
Cells were washed with PBS, incubated in DME at 4 or 37
 
8
 
C for 30 min in
the presence of 10 
 
m
 
M [
 
32
 
P]SPP (64,000 cpm/nmol) (Van Veldhoven and
Mannaerts, 1994), washed with DME containing 0.4 mg/ml fatty acid-free
BSA, and then incubated in DME for the indicated time. After washing
with cold DME, cells were trypsinized, and cellular lipids were extracted
as described (Olivera and Spiegel, 1993). Extracts were applied to silica
gel 60 G plates, which were developed with chloroform/methanol/25 mM
NaH
 
2
 
PO
 
4
 
 (60:35:8, vol/vol), and then exposed to a Phosphor Screen (Mo-
lecular Dynamics, Sunnyvale, CA) for 2 h. Radioactive bands were quanti-
fied using a Storm densitometer with the ImageQuant program (Molecular
Dynamics). Radioactivity in aliquots from each sample was also quantitated 
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by liquid scintillation counting for measurement of SPP uptake. Sphin-
gosine production was measured as described (Lavie et al., 1994).
 
Determination of Tyrosine Phosphorylation of p125
 
FAK
 
HEK293 cells were treated with SPP added as a complex with 4 mg/ml
BSA for the indicated times, washed twice with PBS, and then lysed by
addition of 0.5 ml lysis buffer (50 mM Hepes, pH 7.9, 1% Triton X-100,
100 mM NaCl, 10 mM EDTA, 4 mM sodium pyrophosphate, 10 mM NaF,
1 mM PMSF, 2 mM Na
 
3
 
VO
 
4
 
, and 2 
 
m
 
g/ml aprotinin and leupeptin).
p125
 
FAK
 
 was immunoprecipitated from samples containing equal amounts
of protein with anti-p125
 
FAK
 
 monoclonal antibody (Upstate Biotechnol-
ogy, Inc., Lake Placid, NY). Immunoprecipitates were washed three times
with lysis buffer and separated by 7% SDS-PAGE. Proteins were trans-
ferred to nitrocellulose membranes (Bio-Rad Laboratories) and probed
with monoclonal antiphosphotyrosine 4G10 (Upstate Biotechnology,
Inc.). Bands were visualized with Super Signal chemiluminescent reagent
(Pierce Chemical Co., Rockford, IL).
 
Measurement of Cytoplasmic Free 
Calcium Concentrations
 
Cells were grown on 35-mm plastic tissue culture dishes and loaded with
the fluorescent calcium-sensitive dye, fura-2/AM (5 
 
m
 
M), for 45 min at
37
 
8
 
C in DME supplemented with 60 
 
m
 
g/ml BSA. Subsequently, cells were
washed with Locke’s buffer (137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl
 
2
 
,
0.93 mM CaCl
 
2
 
, 6.5 mM Na
 
2
 
HPO
 
4
 
, 1.5 mM KH
 
2
 
PO
 
4
 
, 1 mg/ml glucose, 1
mg/ml BSA, pH 7.4) and mounted in a 35-mm holder maintained at 30
 
8
 
C.
Changes in fura-2 fluorescence were monitored in single cells by dual exci-
tation imaging using an Attofluor Digital Fluorescence Microscopy Sys-
tem (Atto Instruments Inc., Rockville, MD). [Ca
 
2
 
1
 
]
 
i
 
 was determined from
the ratio of fura-2 fluorescence emission after excitation at wavelengths of
334 and 380 nm (Mattie et al., 1994).
 
Phosphatidic Acid Determination
 
Cells were washed and incubated in DME containing [
 
32
 
P]orthophosphate
(100 
 
m
 
Ci/ml) for 24 h. Cells were then treated with SPP or vehicle alone
for the indicated times, the medium was rapidly removed, and lipids were
extracted (Zhang et al., 1990). Phosphatidic acid was analyzed by thin-layer
chromatography using the organic phase of the mixture of isooctane/ethyl
acetate/acetic acid/water (50:110:20:100) (Zhang et al., 1990). In this system,
phosphatidic acid (
 
R
 
f
 
 
 
5 
 
0.1) was separated from other phospholipids (
 
R
 
f
 
 
 
5
 
0). Lipid standards were visualized with molybdenum blue (Sigma Chemi-
cal Co., St. Louis, MO). Phosphatidic acid was quantified using a Storm
densitometer with the ImageQuant program (Molecular Dynamics).
 
Staining of Apoptotic Nuclei
 
Cells were cultured in serum-free medium in the absence or presence of
the indicated sphingolipids for 15 h, washed in PBS, and fixed in 3.7%
formaldehyde for 10 min. After washing with PBS, fixed cells were then
incubated with bisbenzimide trihydrochloride (24 
 
m
 
g/ml in 30% glycerol/
PBS; Hoechst #33258, Calbiochem) for 10 min. Stained cells were exam-
ined with a Zeiss Photoscope II fluorescent microscope (Thornwood,
NY). Apoptotic cells were distinguished by condensed, fragmented nu-
clear regions. A minimum of 2,000 cells was scored.
 
Quantitation of DNA Fragmentation
 
DNA fragmentation was determined in cells prelabeled with [
 
3
 
H]thymi-
dine (1 
 
m
 
Ci/ml) for 24 h (Duke and Cohen, 1992). Cells were washed gen-
tly twice with serum-free medium and then incubated in the same medium
with the indicated sphingolipids for 5 h at 37
 
8
 
C. Cells were harvested and
lysed in TTE (10 mM Tris, pH 7.4, 10 mM EDTA, 0.2% Triton X-100),
and fragmented DNA was separated from intact chromatin by centrifuga-
tion. Pellets were suspended in TTE, and TCA was added to a final con-
centration of 12.5%. [
 
3
 
H]Thymidine incorporated into both intact and
fragmented DNA was determined by liquid scintillation counting (Duke
and Cohen, 1992). Percent fragmented DNA 
 
5 
 
100 
 
3 
 
[fragmented / (frag-
mented 
 
1
 
 intact chromatin)].
 
Microinjection and Immunostaining
 
Swiss 3T3 fibroblasts were grown on CELLocate gridded glass coverslips
(Eppendorf, Hamburg, Germany) and rendered quiescent by starvation
 
for 24 h in serum-free DME supplemented with transferrin (4 
 
m
 
g/ml) and
fatty acid-free BSA (20 
 
m
 
g/ml). Cells were microinjected on a heated
stage using an Eppendorf Micromanipulator 5171 and Transjector 5246.
400 serum-starved cells were microinjected cytoplasmically with SPP (
 
z
 
10
fl of 500 
 
m
 
M, estimated cytoplasmic concentration 
 
5 
 
5 
 
m
 
M) together with
rabbit IgG (RIgG, 5 mg/ml) as a tracking agent using sterile Femtotips
(Eppendorf) at 100 hPa for 0.2 s. Control cells were microinjected with
rabbit IgG alone. Immediately after microinjection, cells were incubated
in fresh serum-free DME with bromodeoxyuridine (BrdU; 10 mM) for 24 h
at 37
 
8
 
C. Cells were then fixed in acidic ethanol (70%, in 50 mmol/liter gly-
cine buffer, pH 2.0) and stained with mouse monoclonal anti-BrdU anti-
body and anti–mouse Ig-fluorescein according to the manufacturer’s in-
structions (BrdU Labeling and Detection Kit; Boehringer Mannheim
GmbH, Mannheim Germany). Cells were stained for RIgG with a 1:200
dilution of anti-RIgG Texas red–conjugated secondary antibody to local-
ize injected cells. After the coverslips were mounted on slides using the
Molecular Probes Anti-Fade kit (Eugene, OR), cells were analyzed with a
fluorescent microscope (model Photoscope II; Carl Zeiss, Inc.). Cell
counts of nuclear BrdU labeling were determined by fluorescence micros-
copy using a triple band pass filter.
 
Results
 
Specificity of SPP Binding to Edg-1
 
We recently identified the G protein–coupled receptor
Edg-1 as a receptor for SPP (Lee et al., 1998). In an at-
tempt to identify other potential agonists or antagonist of
Edg-1, we examined the effects of structurally related lip-
ids on binding of [
 
32
 
P]SPP to human embryonic kidney 293
fibroblasts stably expressing FLAG epitope–tagged Edg-1
(HEK293
 
edg-1
 
). Only sphinganine-1-phosphate (dihydro-
SPP), which lacks the double bond at the 4 position,
blocked binding in a dose-dependent manner nearly as po-
tently as did unlabeled SPP (
 
K
 
i
 
 
 
5 
 
15 nM) (Fig. 1 
 
A
 
). In
contrast, other related lipids, including sphingosine, the
nonhydrolyzable analogue, SPP-phosphonate (Tarnowski
et al., 1997), a short chain SPP analogue (C8-SPP), 
 
N
 
,
 
N
 
-
dimethylsphingosine, C2-ceramide, sphingosylphosphoryl-
choline (SPC), and N-octanoyl ceramide-1-phosphate (C8-
cer-1-P), did not compete with SPP for binding to Edg-1
(Fig. 1 B).
SPP Decreases cAMP Levels via the Gi-coupled 
Receptor Edg-1
Biochemical evidence and the yeast two-hybrid system in-
dicate that Edg-1 is capable of interaction with Gia1 and
Gia3 (Lee et al., 1996). Moreover, Edg-2 and the canna-
binoid receptors, which are related to the edg family, are
known to be linked to Gi signaling pathways leading to de-
creased levels of cAMP (Howlett, 1995; Hecht et al.,
1996). Therefore, functional coupling of the Edg-1 recep-
tor overexpressed in HEK293 cells in response to its
ligand SPP was investigated. The effect of SPP on cAMP
accumulation was examined after stimulation of adenylate
cyclase with forskolin in the presence of the phosphodi-
esterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) to
ensure that changes in cAMP levels were not mediated by
effects on phosphodiesterase activity. Binding of SPP to
Edg-1 markedly inhibited forskolin-stimulated cAMP ac-
cumulation in a dose-dependent manner (Fig. 2 A), which
correlated closely with binding, as the Kd of Edg-1 for SPP
is 8 nM (Lee et al., 1998). Although lower concentrations
of SPP had no effect on cAMP accumulation induced by
forskolin in vector-transfected cells (HEK293-vector) de-The Journal of Cell Biology, Volume 142, 1998 232
void of Edg-1 expression and specific SPP binding, much
higher concentrations slightly reduced cAMP levels, albeit
to a lesser extent than in cells that express Edg-1 (Fig. 2
A). Thus, the additional decrease in cAMP seen at higher
SPP concentrations may be due to non–receptor-mediated
effects. Similarly to SPP, dihydro-SPP, which also binds to
Edg-1, decreased cAMP levels (Fig. 2 B). In contrast,
other structurally related lipids that do not bind to Edg-1,
including SPC, sphingosine, C8-SPP, C8-cer-1-P, and par-
ticularly SPP-phosphonate, were without effect (Fig. 2 B).
Moreover, pretreatment with N,N-dimethylsphingosine
(10  mM), at a concentration that markedly inhibits sphin-
gosine kinase and production of endogenous SPP, had no
effect on the decreased cAMP accumulation induced by
binding of SPP to Edg-1 (data not shown).
The SPP-induced cAMP decrease in HEK293-edg-1
cells was completely blocked by pretreatment with pertus-
sis toxin, which ADP ribosylates and inactivates Gi and Go
proteins (Fig. 2 C). Therefore, binding of SPP to the ser-
pentine receptor Edg-1 on the cell surface activates a per-
tussis toxin–sensitive Gi protein.
Figure 1. Effects of SPP analogues and other lipids on specific
binding of [32P]SPP to Edg-1. Competition of SPP binding by re-
lated lipids. HEK293–edg-1 cells were incubated in the presence
of 1 nM [32P]SPP with increasing concentrations of unlabeled
SPP, dihydro-SPP, sphingosine, or C2-ceramide (A) or in the
presence of 100 nM of the indicated lipids (B), and binding was
measured as described in Materials and Methods. Specific bind-
ing of SPP to HEK293–edg-1 (total binding minus binding in the
presence of 100-fold excess unlabeled SPP) was 32 fmol/105 cells.
Results are means 6 standard deviations of triplicate determina-
tions.
Figure 2. SPP decreases cAMP levels through the Edg-1 Gi-cou-
pled receptor. (A) HEK293-vector (open bars) or HEK293–edg-1
cells (filled bars) were stimulated with 10 mM forskolin in the
presence of 0.5 mM IBMX and the indicated concentrations of
SPP for 15 min, and levels of cAMP were then measured. The
levels of cAMP in untreated and forskolin-treated cells were 20 6
1.7 and 420 6 30 pmol/106 cells and 10 6 1.5 and 820 6 60 pmol/
106 cells for vector and edg-1–overexpressing cells, respectively.
Results are means 6 SD of triplicate determinations. (B) Effects
of SPP analogues on cAMP accumulation. HEK293–edg-1 cells
were treated with lipids or SPP analogues (100 nM), and forsko-
lin-stimulated cAMP accumulation was determined as described
in A. (C) Pertussis toxin inhibits the effect of SPP on cAMP accu-
mulation. Cells were pretreated in the absence (filled bars) or
presence (open bars) of 200 ng/ml pertussis toxin (PTX) for 3 h
and then were treated for 15 min with forskolin (10 mM) and/or
SPP (100 nM), or combinations, as indicated, and cAMP accumu-
lation was measured.Van Brocklyn et al. Dual Actions of Sphingosine-1-Phosphate 233
SPP Stimulates Non–receptor-mediated Signal 
Transduction Pathways
Recently, it was shown that the decrease in cAMP result-
ing from binding of the endogenous ligand anandamide to
the CB-1 receptor resulted in tyrosine phosphorylation of
focal adhesion kinase (p125FAK) (Derkinderen et al., 1996).
Moreover, we previously showed that SPP enhances phos-
phorylation of p125FAK in Swiss 3T3 cells (Wang et al.,
1997). Surprisingly, we found that SPP-induced tyrosine
phosphorylation of p125FAK was independent of Edg-1 re-
ceptor activation, as the response was greater in cells lacking
the receptor and was even decreased in cells overexpressing
edg-1 (Fig. 3 A). Furthermore, tyrosine phosphorylation of
p125FAK was increased even more at concentrations of
SPP higher than those that saturate Edg-1 binding (Lee et
al., 1998).
In many cell types, SPP has been shown to activate sev-
eral signal transduction pathways (Desai et al., 1992; Chao
et al., 1994; Ghosh et al., 1994; Mattie et al., 1994; Natara-
jan et al., 1994; Bornfeldt et al., 1995; Goodemote et al.,
1995; Choi et al., 1996; Blakesly et al., 1997; Fatatis and
Miller, 1997; Okajima et al., 1997), particularly mobiliza-
tion of calcium and activation of phospholipase D, which
in certain cell types are activated by low concentrations of
SPP. Thus, it was of interest to determine whether these
responses were dependent or independent of activation of
the cell surface receptor Edg-1. As illustrated in Fig. 3 B,
low concentrations of SPP (100 nM) had no effect on cal-
cium mobilization in either vector-transfected or edg-1–
overexpressing HEK293 cells, whereas treatment with 10
mM SPP led to identical increases in [Ca21]i, suggesting
that this response to SPP is not mediated by Edg-1. The
calcium responses were also identical in vector- and edg-1–
transfected NIH 3T3 cells (data not shown). In agreement,
only high, mitogenic concentrations of SPP release cal-
cium from internal sources in Swiss 3T3 fibroblasts (Mat-
tie et al., 1994). Similarly, mobilization of calcium from in-
ternal sources by cannabinoid agonists was also shown to
be independent of activation of the cannabinoid receptor
(Felder et al., 1992). The effects of SPP on activation of
phospholipase D were also Edg-1 receptor independent
and were even attenuated by edg-1 overexpression in NIH
3T3 fibroblasts (Fig. 3 C). Thus, several mitogenic signal
transduction pathways that are thought to be involved in
SPP-induced proliferation are clearly Edg-1 receptor inde-
pendent.
SPP Regulates Cell Proliferation and Survival 
Independently of Edg-1 Expression
Because the most well-established biological response to
SPP is the stimulation of cell growth (Zhang et al., 1991;
Olivera and Spiegel, 1993; Su et al., 1994; Gomez-Munoz
et al., 1995; Goodemote et al., 1995; Wu et al., 1995; Pyne
et al., 1996; Blakesly et al., 1997; Rani et al., 1997), we ex-
amined the effect of SPP on DNA synthesis in several cell
lines expressing different levels of edg-1: SPP is a powerful
Figure 3. SPP stimulates non–Edg-1 receptor-mediated signal
transduction pathways. (A) SPP stimulates tyrosine phosphoryla-
tion of p125FAK independently of Edg-1 expression. HEK293–
edg-1 and vector-transfected HEK293 cells were treated with the
indicated concentrations of SPP for various times, and cell lysates
were immunoprecipitated with anti-p125FAK mAb and analyzed
by Western blotting with anti-Tyr(P) antibody. The arrow indi-
cates the migration p125FAK. (B) SPP-induced changes in intra-
cellular free calcium. Vector and edg-1 stably transfected
HEK293 cells were loaded with fura-2/AM, washed, and incu-
bated at 378C in Locke’s buffer. At the indicated times, SPP (100
nM or 10 mM) was added, and [Ca21]i was determined by fura-2
imaging (Mattie et al., 1994). Subsequent addition of ionomycin
always caused increased [Ca21]i. (C) SPP-induced phosphatidic
acid accumulation. Vector and edg-1 stably transfected HEK293
cells and NIH 3T3 fibroblasts were prelabeled with [32P]i for 24 h
and then stimulated with vehicle (control) or the indicated con-
centrations of SPP for 1 h. Lipids were extracted and separated
by thin-layer chromatography, and [32P]phosphatidic acid was
measured (Zhang et al., 1990). Data are expressed as fold-
increases of [32P]phosphatidic acid. The incorporations of [32P]
into phosphatidic acid in untreated cells were 1,500 6 50 and
1,000  6 100 cpm, and 2,500 6 600 and 3,200 6 200 cpm for vector
and edg-1 stably transfected HEK293 cells and NIH 3T3 fibro-
blasts, respectively, determined from an aliquot of the phospho-
lipid extract containing 150,000 cpm.The Journal of Cell Biology, Volume 142, 1998 234
mitogen for Swiss 3T3 fibroblasts (Zhang et al., 1991; De-
sai et al., 1992; Su et al., 1994; Rani et al., 1997; Wang et al.,
1997) and is also mitogenic for NIH 3T3 fibroblasts, albeit
less potent (Blakesly et al., 1997). In agreement with previ-
ous studies (Zhang et al., 1991; Desai et al., 1992; Su et al.,
1994; Rani et al., 1997; Wang et al., 1997), 10 mM SPP in-
duced marked stimulation of DNA synthesis in Swiss 3T3 fi-
broblasts (Fig 4 A). SPP was less mitogenic for control, vec-
tor-transfected NIH 3T3 fibroblasts (NIH 3T3/pMEX.2),
and least mitogenic for edg-1–transfected NIH 3T3 cells
(NIH 3T3/pMFE1.2), which express human Edg-1.
Northern analysis of HEK293–edg-1 and HEK293-vec-
tor cells using a human edg-1 cDNA probe revealed, as ex-
pected, a prominent band in HEK293–edg-1 cells and no
band in HEK293-vector cells (Fig. 4 B). As edg-1 expres-
sion was expected to be low in mouse fibroblasts, a mouse
edg-1 probe that detects mouse edg-1 more sensitively
than the human probe was used to analyze NIH 3T3 and
Swiss 3T3 cells. Swiss 3T3 cells express the lowest levels of
endogenous  edg-1 mRNA of the three fibroblast lines
tested (Fig. 4 B), which was confirmed by reverse tran-
scriptase PCR analysis (data not shown). NIH 3T3 cells
stably transfected with human edg-1 show the presence of
both mouse and human edg-1 (2.9 and 1.8 kb, respectively;
Fig. 4 B). In agreement, Swiss 3T3 cells showed a low level
of specific binding (Fig. 4 C), whereas NIH–edg-1 cells
have much higher specific [32P]SPP binding (Fig. 4 C).
Thus, it seems that there is no correlation between edg-1
expression and the mitogenic response to SPP (compare
Fig. 4 A, and B and C). In agreement, SPP was not mitoge-
nic for HEK293 cells regardless of whether or not they ex-
pressed Edg-1 (Fig. 4 A).
Although low levels of SPP bound specifically to Swiss
3T3 fibroblasts at 48C, no specific binding could be de-
tected at any concentration of [32P]SPP (up to 10 mM) in
Swiss 3T3 fibroblasts at 378C. However, there was a large,
cell-associated fraction of [32P]SPP (278 pmol per 106 cells)
detected when Swiss 3T3 fibroblasts were incubated with
10 mM [32P]SPP at 378C. This is due to uptake, as there was
extensive intracellular metabolism catalyzed by SPP lyase
and SPP phosphatase, both located in the endoplasmic
reticulum (Van Veldhoven and Mannaerts, 1994; Mandala
et al., 1997), and 57% of the cell-associated SPP was me-
tabolized within 1 h while after 15 h, only 18% of the SPP
still remained intact (data not shown).
To further substantiate the notion that the mitogenic ac-
tions of SPP observed at high concentrations was due to
intracellular actions rather than binding to a cell surface
receptor, we took advantage of our previous observation
that mitogenesis induced by SPP only required a short ex-
posure time (Wang et al., 1997). In agreement, exposure of
Swiss 3T3 fibroblasts to SPP for 30 min at 378C, followed
by washing and replacement of the media, resulted in 50%
of maximum DNA synthesis induced by 24 h of treatment
(Fig. 5 A). In contrast, when Swiss 3T3 fibroblasts were in-
cubated with SPP for 30 min at 48C, to allow binding but
significantly less uptake (Fig. 5 B), there was much less
stimulation of DNA synthesis, suggesting that SPP must
be taken up by cells to produce a mitogenic effect. Fur-
thermore, in another approach to increase uptake and de-
livery of SPP into cells, SPP was mixed with the cationic
lipid, lipofectamine, which forms liposomes that are readily
Figure 4. SPP-stimulated DNA synthesis does not correlate with
Edg-1 expression. (A) Swiss 3T3 fibroblasts (filled bars), vector-
transfected NIH 3T3 cells (hatched bars), NIH 3T3 cells stably
transfected with edg-1 ( open bars), HEK293-vector (stippled
bars), and HEK293–edg-1 cells (gray bars) were grown to conflu-
ence in 24-well tissue culture plates, washed with serum-free
DME containing 5 mg/ml transferrin and 20 mg/ml BSA, and then
stimulated with the indicated concentration of SPP. After 16 h,
cells were pulsed with 1.0 mCi of [3H]thymidine for 8 h, and incor-
poration of [3H]thymidine into trichloroacetic acid–insoluble mate-
rial was measured. Values are the means of triplicate determina-
tions, and standard deviations were routinely less than 10% of the
mean. (B) Northern analysis of Edg-1 expression was performed
on total RNA from the indicated cells as described in Materials
and Methods. A probe corresponding to the mouse edg-1 gene
(Liu and Hla, 1997) was used to detect the low level of edg-1
mRNA present in Swiss 3T3 cells. For analysis of HEK293–edg-1
and HEK293-vector cells, a probe corresponding to the human
edg-1 gene was used (Hla and Maciag, 1990). (C) Specific
[32P]SPP binding to various cell types. Nonspecific (open bars)
and total binding (filled bars) of 1 nM [32P]SPP to Swiss 3T3 fi-
broblasts, vector-transfected NIH 3T3 cells, NIH 3T3 cells stably
transfected with edg-1, vector-transfected HEK293 cells, and edg-
1-transfected HEK293 were measured as described in Materials
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internalized and has been widely used to deliver DNA,
RNA, and protein (Felgner et al., 1987). In this liposome
form, the dose-response for stimulation of DNA synthesis
by SPP was shifted to much lower concentrations (Fig. 5
C) with a corresponding increase in [32P]SPP uptake (Fig.
5 D). Collectively, these results strongly suggest that the
mitogenic effects of SPP are independent of receptor-
mediated actions. In agreement, the nonhydrolyzable
SPP-phosphonate, which does not bind to Edg-1 or stimu-
late the Gi signaling pathway, is as potent a mitogenic
agent for Swiss 3T3 fibroblasts as is SPP (data not shown).
To conclusively demonstrate that SPP stimulates DNA
synthesis intracellularly, we microinjected SPP into the cy-
toplasm of quiescent Swiss 3T3 fibroblasts together with
IgG to identify microinjected cells and examined the in-
corporation of BrdU into nascent DNA 24 h later. Using
double immunofluorescence to visualize injected cells and
BrdU incorporation, it is evident that DNA synthesis is in-
creased after microinjection of SPP, as 6% of injected cells
were positive for BrdU incorporation compared with 1%
of adjacent, noninjected cells in the same field (Fig. 6). It
should be noted that after exogenous treatment of Swiss
3T3 fibroblasts with optimum mitogenic concentrations of
SPP or vehicle alone, 10 and 1% of the cells showed BrdU
staining, respectively. Microinjection of rabbit IgG alone
had no significant effect on DNA synthesis. Moreover, in
contrast to the mitogenic effect of SPP, C8-ceramide-1-P,
which has no effect on [3H]thymidine incorporation when
added exogenously, also had no significant effect on BrdU
incorporation when microinjected into quiescent Swiss
3T3 fibroblasts. It is noteworthy that similarly to the syner-
gistic effect between insulin and SPP on [3H]thymidine in-
corporation (Zhang et al., 1991), microinjected SPP also
potentiated the stimulation of BrdU incorporation by in-
sulin (Fig. 6 H). Thus, induction of DNA synthesis by SPP
does not require interaction with a cell surface receptor to
activate the cellular machinery needed for proliferation. In
addition, DNA synthesis stimulated by microinjected SPP
was insensitive to pertussis toxin treatment, whereas 70%
of that caused by exogenous SPP was blocked by pertussis
toxin (Fig. 6 H), in agreement with our previous results
(Goodemote et al., 1995).
To examine whether the cytoprotective effects of SPP
can also be separated from its binding to Edg-1, we used
two cell lines, HL-60 and PC12 cells, in which SPP is
known to have a strong survival effect (Cuvillier et al.,
1996; Edsall et al., 1997). In agreement with the lack of de-
tectable edg-1 mRNA in HL-60 or PC12 cells (Fig. 4 B),
no specific binding of SPP could be detected in either cell
line (Fig. 7 A). SPP-phosphonate, which lacks the oxygen
atom at the 1 position and does not compete for binding to
Edg-1 (Fig. 1 B), was at least as potent as SPP in suppress-
ing ceramide-mediated apoptosis in HL-60 cells (Fig. 7 B)
and was as potent as SPP in prevention of DNA fragmen-
tation due to serum deprivation in PC12 cells (Fig. 7 C).
These protective effects were specific, because dihydro-
SPP, which lacks the trans double bond present in SPP and
binds to Edg-1 (Fig. 1), did not significantly prevent apop-
tosis either in HL-60 or in PC12 cells.
Discussion
Apparently contradictory reports describe intracellular
and extracellular actions of SPP in diverse cell types (Spie-
Figure 5. SPP-stimulated DNA syn-
thesis correlates with uptake of SPP.
(A) Swiss 3T3 fibroblasts, cultured in
serum-free DME containing 4 mg/ml
insulin, 4 mg/ml transferrin, and 20 mg/ml
BSA, were treated with the indicated
concentrations of SPP at 4 (filled bars)
or 378C (open bars) for 30 min, fol-
lowed by washing and replacement in
the same medium without SPP. Cells
were then incubated for 16 h at 378C,
and [3H]thymidine incorporation was
measured. (B) In duplicate cultures,
uptake was measured after 30 min in-
cubation with 10 mM [32P]SPP. (C)
Swiss 3T3 fibroblasts cultured in se-
rum-free DME were treated with the
indicated concentrations of SPP added
as a complex with 4 mg/ml BSA (open
symbols) or with 5 ml/ml lipofectamine
(filled symbols) for 30 min followed by
washing and replacement with DME
containing 4 mg/ml insulin, 4 mg/ml
transferrin, and 20 mg/ml BSA, and
DNA synthesis was measured 16 h
later. (D) In duplicate cultures, uptake
of [32P]SPP was measured in the ab-
sence (open bars) or presence (filled
bars) of lipofectamine.The Journal of Cell Biology, Volume 142, 1998 236
gel and Milstien, 1995; Spiegel et al., 1996; Moolenaar et al.,
1997). This study demonstrates that SPP indeed has dual ac-
tions, acting as a second messenger to stimulate cell growth
and prevent apoptosis, and as a first messenger through its
cell surface receptor Edg-1 (Lee et al., 1998). Similar to
the effects of the ligands for other closely related G pro-
tein–coupled receptors, such as CB-1 (Bouaboula et al.,
1995; Felder et al., 1995) and Edg-2 (Hecht et al., 1996),
binding of SPP to Edg-1 markedly inhibits cAMP accumu-
lation (Fig. 2) and activates the mitogen-activated protein
(MAP) kinase, ERK-2 (Lee et al., 1998), in a pertussis
toxin–sensitive manner. Although the biological function
of Edg-1 is not completely understood, it was cloned as an
immediate early gene involved in endothelial differentia-
tion (Hla and Maciag, 1990). Binding of SPP to Edg-1 also
induces morphogenetic differentiation of HEK293–edg-1
cells and P-cadherin expression by a Rho-dependent
mechanism (Lee et al., 1998). Thus, SPP might play a role
in angiogenesis since the Kd for SPP binding to Edg-1 is 8
nM (Lee et al., 1998) and SPP is a serum-borne compo-
nent, where its concentration is 480 nM (Yatomi et al.,
1997b). However, because edg-1 expression has been de-
tected in many tissues, including brain, spleen, heart, lung,
placenta, muscle, liver, uterus, and kidney (Liu and Hla,
1997), both Edg-1 and SPP might regulate diverse signal-
ing events.
Specific binding of [3H]SPP has also been detected in
platelets (Yatomi et al., 1997a) and in F10 melanoma cells
(Yamamura et al., 1997). However, the SPP receptors in
these cells have characteristics distinct from Edg-1. In both
cases, the affinity for SPP (Kd . 110 nM) was much lower
than the affinity of Edg-1 for SPP (Kd 5 8 nM), and lyso-
Figure 6. Microinjected SPP stimulates DNA synthesis. Serum-starved Swiss 3T3 cells were microinjected with rabbit IgG together with
vehicle (A–C) or SPP (D–F). Cells were visualized by Texas red fluorescence (red), demonstrating immunoglobulin G localization after
microinjection (A and D). BrdU incorporation into injected and uninjected cells on the same coverslips was visualized by green FITC
fluorescence (B and E). C and F are superimposed images visualized using a triple band pass filter. Yellow-orange color indicates colo-
calization of microinjected SPP with BrdU staining. In G, stimulation of DNA synthesis in cells injected (open bars) with IgG in the ab-
sence or presence of SPP or C8-cer-1-P, as well as in adjacent uninjected cells (filled bars), was assessed by BrdU incorporation. Values
(means 6 SD) are the percentage of cells positive for BrdU staining and correspond to the average of three measurements in which 100
cells were scored. At least 400 cells were microinjected and scored in each experiment. For comparison, BrdU staining of Swiss 3T3 fi-
broblasts treated with vehicle (cross-hatched bar) or with 10 mM exogenous SPP (dotted bar) was also determined. (H) Swiss 3T3 cells
were serum-starved 24 h in the presence of 5 mg/ml insulin and then treated with or without 200 ng/ml pertussis toxin for 3 h. Cells were
then microinjected with rabbit IgG together with vehicle or SPP, or treated with 10 mM exogenous SPP and BrdU incorporation was as-
sessed. In the experiment where SPP was microinjected, 14.5% of adjacent, uninjected cells were positive for BrdU incorporation.Van Brocklyn et al. Dual Actions of Sphingosine-1-Phosphate 237
phosphatidic acid (LPA) was a better competitor than
SPP, suggesting that these receptors can bind both LPA
and SPP (Yatomi et al., 1997a). Similarly, it was found that
a K1 conductance was activated equally well by SPP and
SPC in guinea pig atrial myocytes with heterologous de-
sensitization (Bünemann et al., 1996). However, Edg-1 is
highly selective as a high-affinity receptor for SPP because
SPC and several other closely related lipids have no effect
on either SPP binding or forskolin-stimulated cAMP accu-
mulation. Two receptors closely related to Edg-1, Edg-3
and H218, were shown to confer responsiveness to SPP of
a serum response element-driven reporter gene when ex-
pressed in Jurkat cells and to allow SPP-stimulated 45Ca21
efflux in Xenopus oocytes (An et al., 1997). However,
these authors did not present direct binding data; there-
fore, it is not clear at present whether Edg-3 and H218 are
indeed SPP receptors. Although Edg-1 was ineffective in
these assays, it may not link to the signaling pathways in-
vestigated. In agreement, we have shown here that SPP-
stimulated increased [Ca21]i is not mediated by Edg-1.
Several lines of evidence clearly indicate that mitogene-
sis and prevention of apoptosis induced by SPP are not
mediated through Edg-1. First, the mitogenic action of
SPP correlates with intracellular uptake rather than with
cell surface binding of SPP or with edg-1 expression. In-
deed, SPP is most potently mitogenic for Swiss 3T3 cells,
which have only low specific SPP binding and edg-1 ex-
pression. In addition, the mitogenic effect of SPP requires
micromolar concentrations, whereas putative receptor-
mediated effects of SPP (Bünemann et al., 1996; Postma
et al., 1996; van Koppen et al., 1996) have been shown to
occur in the same nanomolar concentration range as bind-
ing to Edg-1. Second, although we have shown that bind-
ing of SPP to Edg-1 leads to decreases in cAMP levels, in-
hibition of adenylate cyclase may not be associated with
regulation of mitogenesis. In Swiss 3T3 cells, cAMP has
been shown unequivocally to act as a positive effector of
proliferation (Rozengurt, 1986), and it is thus unlikely that
SPP-induced decreases in cAMP play a significant role in
the induction of proliferation. However, in several other
cell types, including Rat-1, airway smooth muscle, and hu-
man foreskin fibroblasts, cAMP is a negative effector of
mitogenesis, and the relevance of reductions in cAMP lev-
els to mitogenic effects of SPP in these cell types is pres-
ently unclear (Pyne and Pyne, 1996). Third, N,N-dimethyl-
sphingosine inhibits sphingosine kinase (Yatomi et al.,
1996) and formation of endogenous SPP, selectively
blocks cellular proliferation induced by PDGF and serum
(Olivera and Spiegel, 1993; Rani et al., 1997) and the cyto-
Figure 7. Effects of SPP and analogues on suppression of apopto-
sis. (A) Lack of specific [32P]SPP binding to HL-60 and PC12
cells. Nonspecific (open bars) and total binding (filled bars) of 1
nM [32P]SPP to HL-60 and PC12 cells was measured. (B) Inhibi-
tion of sphingomyelinase-induced DNA fragmentation by SPP in
HL-60 cells. HL-60 cells were incubated with [3H]thymidine (1
mCi/ml) for 24 h to label DNA, washed, and then treated without
or with 100 mU/ml Staphylococcus aureus sphingomyelinase in
the presence of vehicle or with the indicated concentrations of
SPP (filled squares), SPP-phosphonate (open squares), or dihy-
dro-SPP (filled triangles), added as BSA complexes. After 5 h,
DNA fragmentation was determined from the ratio of unfrag-
mented/fragmented DNA (Cuvillier et al., 1996). Data are ex-
pressed as percent inhibition of DNA fragmentation. Percent
protection from apoptosis 5 100 3 [(fragmentation induced by
SMase) 2 (fragmentation induced by SMase in the presence of
cytoprotective agents)] / [(fragmentation induced by SMase) 2
(fragmentation of untreated controls)]. (C) SPP and its hydroly-
sis-resistant analogue suppress apoptosis in PC12 cells induced by
trophic factor withdrawal. PC12 cells were incubated in serum-
free medium in the absence or presence of 5 mM SPP, dihydro-
SPP, SPP-phosphonate, or NGF (100 ng/ml) for 15 h, fixed in
3.7% formaldehyde, and then stained with bisbenzimide trihy-
drochloride (24 mg/ml in 50% glycerol/PBS; Hoechst #33258, Cal-
biochem) (Edsall et al., 1997). Cells with chromatin condensation
or segmentation of nuclei into three or more fragments were con-
sidered to be apoptotic. A minimum of 2,000 cells in each field
was scored. Values are means 6 SD of triplicate determinations.
Percent protection from apoptosis 5 100 3 [(number of cells with
fragmented nuclei) / (number of cells with fragmented nuclei 1
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protective effects of cytokines (Cuvillier et al., 1996) and
NGF (Edsall et al., 1997), but had no effect on SPP bind-
ing, nor did it affect SPP-mediated decreased cAMP lev-
els. Thus, effects of this sphingosine kinase inhibitor are
not mediated through inhibition of Edg-1 signaling, and it
provides a useful tool for discriminating between intra-
and extracellular actions. Additional evidence that the mi-
togenic effect of SPP is not mediated through a cell surface
receptor comes from the use of the polyanionic drug
suramin, a broad-specificity inhibitor of ligand receptor in-
teractions (Postma et al., 1996; Wang et al., 1997). Suramin
has no effect on SPP-induced p125FAK phosphorylation
and mitogenesis, but it inhibits responses to LPA and SPC
(Wang et al., 1997). The most compelling evidence that the
mitogenic effect of SPP is mediated intracellularly is that
microinjection of SPP causes increased DNA synthesis.
Moreover, because uninjected cells adjacent to SPP micro-
injected cells showed no significant increase in BrdU in-
corporation, it is unlikely that SPP is leaking from microin-
jected cells or from the pipet and stimulating other cells in
autocrine fashion. Since microinjection effectively by-
passes cell surface receptors to introduce SPP directly into
cells, these data conclusively demonstrate that binding to
cell surface receptors is not required for SPP-induced mi-
togenesis, consistent with a role for Edg-1 in morphoge-
netic differentiative (Lee et al., 1998), rather than mitoge-
nic, signaling pathways.
SPP prevents apoptosis induced by trophic factor with-
drawal or by ceramide elevations in PC12 and HL-60 cells,
both of which do not express edg-1 or have detectable SPP
cell surface binding. In addition, metabolically stable SPP-
phosphonate, which does not bind to Edg-1, protects these
cells from apoptosis as potently as does SPP. Conversely,
dihydro-SPP, which binds to and signals via Edg-1, does
not have any significant cytoprotective effect. Thus, simi-
larly to its mitogenic effect, the survival effect of SPP is in-
dependent of Edg-1 and is probably mediated intracellu-
larly. In agreement, unfertilized oocytes treated with the
anticancer drug doxorubicin undergo apoptosis accompa-
nied by increased ceramide levels (Perez et al., 1997).
Doxorubicin-induced apoptosis was completely blocked
by microinjection of SPP, indicating that oocyte destruc-
tion caused by chemotherapy can be prevented by manip-
ulation of intracellular levels of SPP (Perez et al., 1997).
SPP has also been shown to activate several signal trans-
duction pathways, most of which have been associated
with mitogenic signaling and, as shown here, are unrelated
to Edg-1–mediated pathways. SPP increased [Ca21]i to the
same level in HEK293-vector cells and HEK293 cells
overexpressing Edg-1. Interestingly, it has been shown
that cannabinoids can also increase [Ca21]i independently
of receptor expression (Felder et al., 1992). Moreover, simi-
lar to SPP (Mattie et al., 1994), calcium mobilization was in-
dependent of inositol trisphosphate formation (Felder et
al., 1992). Our results indicate that these responses to SPP
are not mediated by Edg-1 and suggest that SPP may acti-
vate these pathways by acting intracellularly. However, we
cannot exclude the possibility that other SPP receptors ex-
ist, which may lead to activation of these pathways. The fact
that tyrosine phosphorylation of p125FAK and activation of
phospholipase D by SPP was attenuated in HEK293–edg-1
cells suggests that Edg-1 may in some cases oppose the mi-
togenic signaling of SPP. This is a reasonable proposal
since Edg-1 is thought to be involved in endothelial cell
differentiation (Hla and Maciag, 1990) and mediates mor-
phogenetic differentiation of HEK293–edg-1 cells treated
with SPP (Lee et al., 1998). However, we cannot exclude
the possibility that in certain cell types, binding of SPP to
Edg-1 might be a contributing factor involved in cellular
proliferation. Transient activation of MAP kinase, in con-
trast to sustained and robust activation, might lead to cel-
lular proliferation rather than differentiation (Marshall,
1995). Binding of SPP to Edg-1 in Cos-7 cells transiently
transfected with edg-1 stimulates MAP kinase in a pertussis
toxin–sensitive manner (Lee et al., 1998). This might explain
the observation that SPP activates MAP kinase and DNA
synthesis in Swiss 3T3 fibroblasts by both pertussis toxin–
sensitive and –insensitive pathways (Goodemote et al.,
1995; Wu et al., 1995). It is noteworthy that in these cells,
62% of SPP-stimulated DNA synthesis is insensitive to
pertussis toxin. (Stimulation by SPP is 8.4- and 5.2-fold in
the absence or presence of 100 ng/ml pertussis toxin, respec-
tively.) SPP-stimulated DNA synthesis was also partially in-
sensitive to pertussis toxin in the presence of insulin (Fig. 6
H). This correlates with our microinjection experiments,
which showed that microinjected SPP gave 60% of the re-
sponse of exogenous SPP (Fig. 6 G) and 41% of the re-
sponse to exogenous SPP in the presence of insulin (Fig. 6
H). In agreement, pertussis toxin decreased DNA synthe-
sis stimulated by exogenous SPP to approximately the
level of that seen in response to microinjected SPP.
While ceramide acts as a mediator of stress responses,
causing cell cycle arrest and/or apoptosis (Hannun, 1996),
SPP counteracts these effects (Cuvillier et al., 1996; Edsall
et al., 1997). Thus, we have suggested that the balance of
cellular levels of SPP and ceramide is a critical factor that
determines cell fate (Cuvillier et al., 1996). Similarly, heat
stress in Saccharomyces cerevisiae causes the accumulation
of phytosphingosine, dihydrosphingosine, and ceramide
(Dickson et al., 1997; Jenkins et al., 1997) and activates
transcription of the global stress response element, indi-
cating a role for sphingolipid metabolites as stress signals
(Dickson et al., 1997). In contrast, deletion of long chain
sphingoid base phosphate phosphatase leads to the accu-
mulation of phosphorylated long chain sphingoid bases
and reduced ceramide levels, and concomitant enhancement
of survival upon severe heat shock (Mandala et al., 1997).
Thus, it seems that the ceramide/SPP rheostat is an evolu-
tionarily conserved stress regulatory mechanism. Therefore,
in addition to its role as a ligand for Edg-1, the cellular
level of SPP is important for regulation of cell prolifera-
tion and survival. Collectively, this data indicates that SPP
is a prototype for a novel class of lipid mediators that act
both extracellularly as ligands for cell surface receptors
and intracellularly as second messengers.
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